STAY! Think easy. Think liquid. Think METACAM.


Important Safety Information: As a class, cyclo-oxygenase inhibitory NSAIDs may be associated with gastrointestinal, kidney, or liver side effects. The most common side effects reported in fi eld studies were vomiting and soft stool/diarrhea. These are usually mild, but may be serious. If side effects occur, pet owners should halt therapy and contact their veterinarian. Pets should be evaluated for pre-existing conditions and currently prescribed medications prior to treatment with METACAM, then monitored regularly while on therapy. Concurrent use with another NSAID, corticosteroid, or nephrotoxic medication should be avoided or monitored closely. Please see complete product information in this publication or at www.metacam.com.


METACAM is a registered trademark of Boehringer Ingelheim Vetmedica GmbH, licensed to Boehringer Ingelheim Vetmedica, Inc. © 2011 Boehringer Ingelheim Vetmedica, Inc.


Dogs could teach your clients a thing or two about compliance


And so can Partners in Compliance, a program that helps clients stay with their dog’s NSAID therapy


 Provides personalized, turnkey tools for clinics to drive ongoing client compliance  Offers clients incentives to schedule return visits and continue treatment


 Makes titrating down to the lowest effective dose easy using a computer-generated dosing schedule


 Helps clients maintain long-term therapy with Metacam® NSAID with a liquid formulation


(meloxicam), the only oral


To enroll, contact your Boehringer Ingelheim representative. For more information, visit www.metacam.com/thinkcompliance.


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84